# COL6A1

## Overview
The COL6A1 gene encodes the collagen type VI alpha 1 chain, a vital component of the extracellular matrix (ECM) that plays a significant role in maintaining tissue integrity and function. This gene is responsible for producing one of the three alpha chains that form type VI collagen, a microfibrillar collagen that contributes to the structural framework of various connective tissues. The protein encoded by COL6A1 is characterized by a central triple helical domain and large globular domains, which are essential for its function in forming stable microfibrils. These microfibrils are crucial for anchoring the basement membrane to the surrounding matrix and facilitating interactions with other ECM proteins and cell surface receptors. Type VI collagen is involved in numerous biological processes, including cell growth, apoptosis, and mechanotransduction, and is particularly important in load-bearing tissues such as cartilage, tendon, and muscle (Gregory2024The; Lamandé2018Collagen).

## Structure
The COL6A1 gene encodes the α1(VI) chain of type VI collagen, a crucial component of the extracellular matrix. The primary structure of the α1(VI) chain includes a central triple helical domain characterized by repeating Gly-Xaa-Yaa sequences, flanked by large N- and C-terminal globular domains. These globular domains contain motifs homologous to von Willebrand factor type A domains (Martoni2013Characterization; Bushby2013Collagen). 

The secondary structure of the α1(VI) chain involves the formation of a stable triple helix, which is essential for the protein's function. The tertiary structure is defined by the folding of the globular domains and the triple helical region, contributing to the overall stability and function of the protein (Lamandé2018Collagen).

In terms of quaternary structure, the α1(VI) chain combines with α2(VI) and α3(VI) chains to form a heterotrimeric monomer. This monomer further assembles into disulfide-bonded dimers and tetramers, which are secreted and associate end-to-end to form beaded microfibrils in the extracellular matrix (Martoni2013Characterization; Bushby2013Collagen).

Post-translational modifications of the α1(VI) chain include glycosylation, which varies between its non-triple helical and triple helical forms (Sato2018Type). These modifications are crucial for the protein's stability and function.

## Function
The COL6A1 gene encodes the alpha 1 chain of type VI collagen, a crucial component of the extracellular matrix (ECM) that forms a microfibrillar network. This network plays a significant role in maintaining tissue structure and function by anchoring the basement membrane to the surrounding matrix and interacting with various ECM proteins and cell surface receptors (Gregory2024The; Lamandé2018Collagen). In healthy human cells, type VI collagen is involved in the assembly and secretion of collagen VI heterotrimers, which are essential for forming beaded microfibrils that provide cellular anchorage and transduce mechanosensory signals in load-bearing tissues such as cartilage, tendon, and muscle (Gregory2024The).

Type VI collagen influences cell growth, metabolism, and apoptosis, and regulates the activity, retention, and survival of progenitor cells in various tissues, including bone, adipose, muscle, hematopoietic, neural, and epithelium (Gregory2024The; Lamandé2018Collagen). It also affects the composition and organization of the ECM, impacting fibroblast morphology and migration, which is crucial for maintaining the integrity and function of the dermal matrix (Theocharidis2016Type). The protein is active in connective tissues, contributing to skin, muscle, and organ function (Lettmann2014Col6a1).

## Clinical Significance
Mutations in the COL6A1 gene are associated with several muscular dystrophies, primarily Bethlem myopathy (BM) and Ullrich congenital muscular dystrophy (UCMD). Bethlem myopathy is characterized by muscle weakness, joint contractures, and respiratory issues, typically manifesting in the first two decades of life. Mutations in COL6A1, such as the common splicing mutation COL6A1 IVS 14 + 1 G > A, lead to exon skipping and a reduction in normal collagen VI microfibrils, contributing to the BM phenotype (Lucioli2005Detection). Missense mutations involving glycine substitutions in the triple helical domains of COL6A1 are also implicated in BM (Choi2020Coexistence).

Ullrich congenital muscular dystrophy presents with more severe symptoms, including muscular hypotonia, weakness, and joint contractures. In UCMD, heterozygous in-frame deletions in COL6A1 disrupt collagen VI assembly, affecting its secretion and function in the extracellular matrix. These mutations can lead to a severe phenotype by impairing the formation of collagen VI dimers and tetramers, crucial for muscle function (Pan2003New). The variable penetrance of COL6A1 mutations complicates genetic counseling and prenatal diagnosis, as similar mutations can result in different clinical outcomes (Peat2007Variable).

## Interactions
The COL6A1 gene encodes the alpha 1 chain of type VI collagen, which is a key component of the extracellular matrix (ECM) and participates in various protein interactions. Type VI collagen interacts with other collagen types, including type I, II, and IV, as well as ECM molecules such as fibronectin, biglycan, and decorin (Cescon2015Collagen; Bidanset1992Binding; Kuo1997Type). The interaction with type IV collagen is particularly significant, as it helps anchor endothelial basement membranes, suggesting a structural role in tissue integrity (Kuo1997Type).

Type VI collagen also interacts with proteoglycans like NG2 and decorin. The NG2 chondroitin sulfate proteoglycan binds to type VI collagen, potentially facilitating cellular interactions with the ECM (Stallcup1990Interaction). Decorin binds to type VI collagen through its core protein, specifically in the segment containing leucine-rich repeats, which may influence the structural organization of the ECM (Bidanset1992Binding).

In skeletal muscle, type VI collagen is essential for the basement membrane of myofiber endomysium, interacting with integrins and CSPG4, although the specific pathways for signal transduction remain unclear (Cescon2015Collagen). These interactions are crucial for maintaining tissue architecture and facilitating cell adhesion and migration.


## References


[1. (Lettmann2014Col6a1) Sandra Lettmann, Wilhelm Bloch, Tobias Maaß, Anja Niehoff, Jan-Niklas Schulz, Beate Eckes, Sabine A. Eming, Paolo Bonaldo, Mats Paulsson, and Raimund Wagener. Col6a1 null mice as a model to study skin phenotypes in patients with collagen vi related myopathies: expression of classical and novel collagen vi variants during wound healing. PLoS ONE, 9(8):e105686, August 2014. URL: http://dx.doi.org/10.1371/journal.pone.0105686, doi:10.1371/journal.pone.0105686. This article has 33 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0105686)

[2. (Bidanset1992Binding) D.J. Bidanset, C Guidry, L.C. Rosenberg, H.U. Choi, R Timpl, and M Hook. Binding of the proteoglycan decorin to collagen type vi. Journal of Biological Chemistry, 267(8):5250–5256, March 1992. URL: http://dx.doi.org/10.1016/s0021-9258(18)42759-7, doi:10.1016/s0021-9258(18)42759-7. This article has 263 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/s0021-9258(18)42759-7)

[3. (Kuo1997Type) Huey-Ju Kuo, Cheryl L. Maslen, Douglas R. Keene, and Robert W. Glanville. Type vi collagen anchors endothelial basement membranes by interacting with type iv collagen. Journal of Biological Chemistry, 272(42):26522–26529, October 1997. URL: http://dx.doi.org/10.1074/jbc.272.42.26522, doi:10.1074/jbc.272.42.26522. This article has 244 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.272.42.26522)

[4. (Theocharidis2016Type) Georgios Theocharidis, Zoe Drymoussi, Alexander P. Kao, Asa H. Barber, David A. Lee, Kristin M. Braun, and John T. Connelly. Type vi collagen regulates dermal matrix assembly and fibroblast motility. Journal of Investigative Dermatology, 136(1):74–83, January 2016. URL: http://dx.doi.org/10.1038/jid.2015.352, doi:10.1038/jid.2015.352. This article has 86 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/jid.2015.352)

[5. (Choi2020Coexistence) Eunseok Choi, Soyoung Shin, Sangjee Lee, Sook Joung Lee, and Joonhong Park. Coexistence of digenic mutations in the collagen vi genes (col6a1 and col6a3) leads to bethlem myopathy. Clinica Chimica Acta, 508:28–32, September 2020. URL: http://dx.doi.org/10.1016/j.cca.2020.05.011, doi:10.1016/j.cca.2020.05.011. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.cca.2020.05.011)

[6. (Bushby2013Collagen) Kate M. D. Bushby, James Collins, and Debbie Hicks. Collagen Type VI Myopathies, pages 185–199. Springer Netherlands, December 2013. URL: http://dx.doi.org/10.1007/978-94-007-7893-1_12, doi:10.1007/978-94-007-7893-1_12. This article has 93 citations.](https://doi.org/10.1007/978-94-007-7893-1_12)

[7. (Stallcup1990Interaction) W B Stallcup, K Dahlin, and P Healy. Interaction of the ng2 chondroitin sulfate proteoglycan with type vi collagen. The Journal of cell biology, 111(6):3177–3188, December 1990. URL: http://dx.doi.org/10.1083/jcb.111.6.3177, doi:10.1083/jcb.111.6.3177. This article has 138 citations.](https://doi.org/10.1083/jcb.111.6.3177)

[8. (Gregory2024The) Carl A. Gregory, Jocelyn Ma, and Sebastian Lomeli. The coordinated activities of collagen vi and xii in maintenance of tissue structure, function and repair: evidence for a physical interaction. Frontiers in Molecular Biosciences, March 2024. URL: http://dx.doi.org/10.3389/fmolb.2024.1376091, doi:10.3389/fmolb.2024.1376091. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fmolb.2024.1376091)

[9. (Cescon2015Collagen) Matilde Cescon, Francesca Gattazzo, Peiwen Chen, and Paolo Bonaldo. Collagen vi at a glance. Journal of Cell Science, January 2015. URL: http://dx.doi.org/10.1242/jcs.169748, doi:10.1242/jcs.169748. This article has 168 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1242/jcs.169748)

[10. (Martoni2013Characterization) Elena Martoni, Stefania Petrini, Cecilia Trabanelli, Patrizia Sabatelli, Anna Urciuolo, Rita Selvatici, Adele D’Amico, Sofia Falzarano, Enrico Bertini, Paolo Bonaldo, Alessandra Ferlini, and Francesca Gualandi. Characterization of a rare case of ullrich congenital muscular dystrophy due to truncating mutations within the col6a1 gene c-terminal domain: a case report. BMC Medical Genetics, June 2013. URL: http://dx.doi.org/10.1186/1471-2350-14-59, doi:10.1186/1471-2350-14-59. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1471-2350-14-59)

[11. (Lucioli2005Detection) S. Lucioli, B. Giusti, E. Mercuri, O. Camacho Vanegas, L. Lucarini, V. Pietroni, A. Urtizberea, R. Ben Yaou, M. de Visser, A. J. van der Kooi, C. Bönnemann, S. T. Iannaccone, L. Merlini, K. Bushby, F. Muntoni, E. Bertini, M. -L. Chu, and G. Pepe. Detection of common and private mutations in the col6a1 gene of patients with bethlem myopathy. Neurology, 64(11):1931–1937, June 2005. URL: http://dx.doi.org/10.1212/01.wnl.0000163990.00057.66, doi:10.1212/01.wnl.0000163990.00057.66. This article has 46 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1212/01.wnl.0000163990.00057.66)

[12. (Pan2003New) Te-Cheng Pan, Rui-Zhu Zhang, Dominick G. Sudano, Suely K. Marie, Carsten G. Bönnemann, and Mon-Li Chu. New molecular mechanism for ullrich congenital muscular dystrophy: a heterozygous in-frame deletion in the col6a1 gene causes a severe phenotype. The American Journal of Human Genetics, 73(2):355–369, August 2003. URL: http://dx.doi.org/10.1086/377107, doi:10.1086/377107. This article has 126 citations.](https://doi.org/10.1086/377107)

[13. (Peat2007Variable) Rachel A. Peat, Naomi L. Baker, Kristi J. Jones, Kathryn N. North, and Shireen R. Lamandé. Variable penetrance of col6a1 null mutations: implications for prenatal diagnosis and genetic counselling in ullrich congenital muscular dystrophy families. Neuromuscular Disorders, 17(7):547–557, July 2007. URL: http://dx.doi.org/10.1016/j.nmd.2007.03.017, doi:10.1016/j.nmd.2007.03.017. This article has 35 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.nmd.2007.03.017)

[14. (Sato2018Type) Takamichi Sato, Ryo Takano, Kazuhiro Tokunaka, Kan Saiga, Arihiro Tomura, Hidemitsu Sugihara, Toshihiko Hayashi, Yasutada Imamura, and Makoto Morita. Type vi collagen α1 chain polypeptide in non-triple helical form is an alternative gene product of col6a1. The Journal of Biochemistry, 164(2):173–181, April 2018. URL: http://dx.doi.org/10.1093/jb/mvy040, doi:10.1093/jb/mvy040. This article has 9 citations.](https://doi.org/10.1093/jb/mvy040)

[15. (Lamandé2018Collagen) Shireen R. Lamandé and John F. Bateman. Collagen vi disorders: insights on form and function in the extracellular matrix and beyond. Matrix Biology, 71–72:348–367, October 2018. URL: http://dx.doi.org/10.1016/j.matbio.2017.12.008, doi:10.1016/j.matbio.2017.12.008. This article has 119 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.matbio.2017.12.008)